.jpg?#)
Veru Stock Analysis: June 2026 Momentum and Key Resistance
On June 4, Veru stock surged dramatically, climbing from around $2.18 to an intraday high of $7.33 before closing at $4.23. This explosive move was triggered by a clinical supply agreement with Novo Nordisk to co-evaluate enobosarm in a Phase 2b obesity trial. The key question is whether Veru stock’s close above $4 signals a...
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
